Aveanna Healthcare Holdings Inc. (AVAH) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AVAH Revenue Growth
Revenue Breakdown (FY 2025)
AVAH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
AVAH Revenue Analysis (2018–2025)
As of May 8, 2026, Aveanna Healthcare Holdings Inc. (AVAH) generated trailing twelve-month (TTM) revenue of $2.43 billion, reflecting exceptional growth of +27.4% year-over-year. The most recent quarter (Q4 2025) recorded $662.5 million in revenue, up 6.5% sequentially.
Looking at the longer-term picture, AVAH's 5-year compound annual growth rate (CAGR) stands at +10.2%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $2.43 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows AVAH's business is primarily driven by Private Duty Services (82%), Home Health And Hospice (10%), and Medical Solutions (8%). With over half of revenue concentrated in Private Duty Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PNTG (+36.8% YoY), ADUS (+19.6% YoY), and HCSG (+7.1% YoY), AVAH has underperformed the peer group in terms of revenue growth. Compare AVAH vs PNTG →
AVAH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AVAHCurrent | $2.4B | +27.4% | +10.2% | 10.9% | |
 PNTG | $948M | +36.8% | +19.4% | 5.4% | |
 ADUS | $1.4B | +19.6% | +13.2% | 9.7% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 MMS | $5.4B | -1.4% | +9.4% | 10.6% |
AVAH Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.43B | +20.2% | $805.2M | 33.1% | $265.4M | 10.9% |
| 2024 | $2.02B | +6.8% | $635.5M | 31.4% | $139.8M | 6.9% |
| 2023 | $1.90B | +6.0% | $595.4M | 31.4% | $8.1M | 0.4% |
| 2022 | $1.79B | +6.5% | $553.2M | 30.9% | $-642,276,000 | -35.9% |
| 2021 | $1.68B | +12.3% | $542.4M | 32.3% | $-36,111,000 | -2.2% |
| 2020 | $1.50B | +8.0% | $454.5M | 30.4% | $-3,487,000 | -0.2% |
| 2019 | $1.38B | +10.4% | $419.3M | 30.3% | $39.0M | 2.8% |
| 2018 | $1.25B | - | $394.3M | 31.5% | $39.0M | 3.1% |
See AVAH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVAH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVAH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAVAH — Frequently Asked Questions
Quick answers to the most common questions about buying AVAH stock.
Is AVAH's revenue growth accelerating or slowing?
AVAH revenue is accelerating at +27.4% year-over-year, exceeding the 5-year CAGR of +10.2%. TTM revenue reached $2.4B. Growth momentum has increased versus prior periods.
What is AVAH's long-term revenue growth rate?
Aveanna Healthcare Holdings Inc.'s 5-year revenue CAGR of +10.2% reflects the sustained expansion pattern. Current YoY growth of +27.4% is above this long-term average.
How is AVAH's revenue distributed by segment?
AVAH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.